Bortezomib
Onco
Daily
Twitter
Facebook
Youtube
RSS Feed
Linkedin
Facebook
RSS
Twitter
Youtube
Linkedin
July, 2024
July 2024
M
T
W
T
F
S
S
1
2
3
4
5
6
7
8
9
10
11
12
13
14
15
16
17
18
19
20
21
22
23
24
25
26
27
28
29
30
31
« Jun
Bortezomib
Jul 3, 2024, 06:28 |
Blog
Yelak Biru: Is myeloma science and clinical progress fast or slow?
Yelak Biru, President and CEO at the International Myeloma Foundation, shared on X: "Is myeloma…
Jun 29, 2024, 13:39 |
Insight
Myeloma Paper of the Day, June 29th, suggested by Robert Orlowski
Robert Orlowski shared on X: "Myeloma Paper of the Day: Real-world analysis of renally impaired…
Jun 20, 2024, 12:25 |
Insight
Luciano Costa: Some considerations on long-term follow-up of the CASSIOPEIA trial
Luciano Costa, a Professor at the University of Alabama at Birmingham, recently shared a post…
Jun 7, 2024, 16:50 |
Insight
Myeloma Paper of the Day, June 7th, suggested by Robert Orlowski
Robert Orlowski shared on X: "Myeloma Paper of the Day: Response rate and EFS to…
Jun 5, 2024, 14:51 |
Blog
Diko Kazandjian: IsaVRD more is better
Dickran (Diko) Kazandjian, Professor of Medicine at the Sylvester Comprehensive Cancer Center and Board Member…
Jun 4, 2024, 14:44 |
Insight
Myeloma Paper of the Day, June 4th, suggested by Robert Orlowski
Robert Orlowski shared on X: "Myeloma Paper of the Day: Phase III BENEFIT trial shows…
Jun 2, 2024, 15:31 |
Insight
Myeloma Paper of the Day, June 2nd, suggested by Robert Orlowski
Robert Orlowski shared on X: "Myeloma Paper of the Day: DREAMM-7 study shows belantamab/bortezomib/dexamethasone superior…
May 14, 2024, 16:12 |
Insight
Myeloma Paper of the Day, May 14th, suggester by Robert Orlowski
Robert Orlowski, Director of Myeloma Section at MD Anderson Cancer Center, shared on X: "Myeloma…
May 8, 2024, 02:28 |
Insight
Myeloma Paper of the Day, May 7th, suggested by Robert Orlowski
Robert Orlowski, Director of Myeloma Section at MD Anderson Cancer Center, shared on X/Twitter: "Myeloma…
Apr 20, 2024, 05:56 |
Insight
Myeloma Paper of the Day suggested by Robert Orlowski, April 18th
Robert Orlowski, Director of the Myeloma Section at MD Anderson Cancer Center, shared on X:…
Mar 1, 2024, 18:37 |
Drugs
Vincent Rajkumar: How many years of life gained because of FDA accelerated approval in myeloma?
Vincent Rajkumar, Editor-in-Chief at the Blood Cancer Journal, shared a thread on X/Twitter: "How many…
Jan 6, 2024, 11:43 |
Blog
Manni Mohyuddin: Carfilzomib is NOT better than bortezomib for newly diagnosed myeloma
Manni Mohyuddin, Assistant Professor at the Huntsman Cancer Institute at the University of Utah, shared on…
Dec 24, 2023, 18:13 |
Insight
Oncology Brothers: ASH23 Myeloma Highlights with Jens Hillengass:
Oncology Brothers shared on their X/Twitter page: "ASH23 Myeloma Highlights with Jens Hillengass. - PERSEUS…
Aug 13, 2023, 10:01 |
Blog
,
Drugs
Rahul Banerjee: How do we standardize the standard of care for bortezomib (Velcade) in multiple myeloma?
Rahul Banarjee, Assistant Professor in the Division of Medical Oncology at the University of Washington,…
All:
14
Posts:
1 - 100
OncoDaily at ASCO 2024: OncoDaily Party, Yvonne Award and much more
Tedros Adhanom Ghebreyesus received University of Nicosia’s Honorary Doctorate
Lisa A. Lacasse: A major milestone towards Congress passing the bipartisan MCED Act
July is Sarcoma Awareness Month
25 Posts You Should Not Miss From ESMOGI24!
Facebook
RSS Feed
Twitter
Linkedin
Youtube